Genetic variation in the dopamine D4 receptor (DRD4) gene and smoking cessation: follow-up of a randomised clinical trial of transdermal nicotine patch.
about
Dopamine D4 receptors in psychostimulant addictionA review of pharmacogenetic studies of substance-related disordersConverging findings from linkage and association analyses on susceptibility genes for smoking and other addictions.Common and unique biological pathways associated with smoking initiation/progression, nicotine dependence, and smoking cessation.Cognitive effects of nicotine: genetic moderators.Gene and gene by sex associations with initial sensitivity to nicotine in nonsmokers.Sex heterogeneity in pharmacogenetic smoking cessation clinical trialsEffects of nicotine deprivation and replacement on BOLD-fMRI response to smoking cues as a function of DRD4 VNTR genotype.Nicotine dependence as a moderator of genetic influences on smoking cessation treatment outcome.Pharmacogenetics of nicotine addiction: role of dopamineDopamine D4 receptor gene variation moderates the efficacy of bupropion for smoking cessation.Pharmacogenetic Optimization of Smoking Cessation Treatment.The DRD4 exon 3 VNTR polymorphism and addiction-related phenotypes: a review.Pharmacogenetics of smoking cessation in general practice: results from the patch II and patch in practice trialsCHRNA3 rs1051730 genotype and short-term smoking cessationBiomarkers to optimize the treatment of nicotine dependence.Gender Considerations in Addiction: Implications for Treatment.Genetics of nicotine dependence and pharmacotherapy.Genetic analysis of polymorphisms in dopamine receptor and transporter genes for association with smoking among cancer patientsEffects of nicotine on emotional distraction of attentional orienting: evidence of possible moderation by dopamine type 2 receptor genotype.The DRD4 exon III VNTR, bupropion, and associations with prospective abstinence.Neuroimaging, genetics and the treatment of nicotine addictionIdentification of pharmacogenetic markers in smoking cessation therapy.Genetic variation in the dopamine pathway and smoking cessation.Dopamine and opioid gene variants are associated with increased smoking reward and reinforcement owing to negative mood.Bumps along the translational pathway: anticipating uptake of tailored smoking cessation treatmentEffects of dopaminergic genes, prenatal adversities, and their interaction on attention-deficit/hyperactivity disorder and neural correlates of response inhibition.Pharmacogenetics of alcohol, nicotine and drug addiction treatments.Pharmacotherapy for smoking cessation: current advances and research topics.CNS genes implicated in relapseDopaminergic genetic variation moderates the effect of nicotine on cigarette reward.DRD2 C313T and DRD4 48-bp VNTR polymorphisms and physical activity of healthy men in Lower Silesia, Poland (HALS study).Dopamine D4 receptor VNTR polymorphism associated with greater risk for substance abuse among adolescents with disruptive behavior disorders: Preliminary results.Pharmacotherapy for smoking cessation: effects by subgroup defined by genetically informed biomarkers.Modeling gene-environment interaction in longitudinal data: Risk for neuroticism due to interaction between maternal care and the Dopamine 4 Receptor gene (DRD4)
P2860
Q27026759-10397871-9C8F-4DBB-9886-9DA23BE0C586Q27312296-605E0416-65B1-481D-8FB7-490155BAFCFAQ30276828-251EF69D-AB02-429E-AA56-C880807309A5Q30435362-14CC26D5-8CA1-42A6-8802-BE0F773C3342Q30474904-A3690966-7586-4200-9870-16386DCC475CQ30486679-EE131896-D886-4842-8608-2F836E5FAB00Q33605769-07CF86CB-BE2D-4886-996D-A7CFADE4DC30Q33813158-33E029C6-51E3-4EBF-89AD-ADC2513E0043Q33893086-CB4715E1-8B7C-41CB-ADB2-4DF602DDFCA8Q34132214-4BB24AFD-F4BE-4636-B4B8-B502E9C326BBQ34311649-83633869-1990-4430-AE11-0134B59E5E7AQ34542169-9A2401EE-BA67-4398-A020-F239446F180EQ34972111-B7C7BB29-492B-44E3-95FF-7B1F985B34F6Q35022995-908A79CC-4578-4A21-9DEF-7F0A73A83885Q35231050-2B50B319-3CDB-490E-B456-43A75C8EC841Q35773685-CAF3B3A5-21BA-499B-8BC8-F990B214A12EQ36082618-EF19B379-53C5-4F05-856C-A0F7ED9ABB3AQ36453486-081CC615-F2F2-4243-A219-A0CFBD36D080Q36829619-33E3D8FA-4945-4E74-B976-A16C411E6155Q36899798-04C07540-2A78-49DB-8931-9F24CDC6178DQ36929824-432B7133-BA43-42D9-A2CF-0629CEBC7E58Q37010016-1A2913D8-CCF7-4F15-A5EA-5D54C108B82EQ37127185-51B80D97-C8CC-4E6B-8C63-4C5745B4B768Q37264547-9CA9F2B7-EAAF-4684-BD61-66A00F194D62Q37280300-59B7D1BF-4860-49D8-A869-781E4234EFC8Q37438867-8F9761D0-9BAB-4546-BEBE-08A6E37460AAQ37730405-5B19FE3E-6BEB-4149-B4BC-3D641F69A76CQ37848476-0391A595-A956-4963-9D9D-3962E10D14B3Q37863092-6FAFE120-C66D-4F41-A0C6-6477D03F7029Q38448419-616B6B37-827F-4FE2-81A6-19259554F635Q40397072-E9C1EB6D-C601-41C7-83FD-E62284BB15E7Q44065452-8ACAB12D-DA25-4341-9A6C-587C6148EC8BQ45023793-81AED8B8-5955-407C-8FF1-75861E38AB2AQ48015634-0942153F-138D-4B0A-905B-A9986AB461EDQ57997615-49E124E0-8BD2-4E90-B8D7-677A0065AEEF
P2860
Genetic variation in the dopamine D4 receptor (DRD4) gene and smoking cessation: follow-up of a randomised clinical trial of transdermal nicotine patch.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Genetic variation in the dopam ...... of transdermal nicotine patch.
@ast
Genetic variation in the dopam ...... of transdermal nicotine patch.
@en
type
label
Genetic variation in the dopam ...... of transdermal nicotine patch.
@ast
Genetic variation in the dopam ...... of transdermal nicotine patch.
@en
prefLabel
Genetic variation in the dopam ...... of transdermal nicotine patch.
@ast
Genetic variation in the dopam ...... of transdermal nicotine patch.
@en
P2093
P2860
P356
P1476
Genetic variation in the dopam ...... of transdermal nicotine patch.
@en
P2093
E C Johnstone
M F G Murphy
R T Walton
P2860
P2888
P304
P356
10.1038/SJ.TPJ.6500447
P577
2007-03-27T00:00:00Z
P5875
P6179
1028305315